United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read General business news Nu Holdings reports strong 2024 results with $11.5bn revenue and 22% customer growth Nu Holdings Ltd., one of the world’s largest digital financial services companies, has reported a significant surge in… byPallavi MadhirajuFebruary 21, 2025